Ignite Creation Date:
2024-05-06 @ 6:32 PM
Last Modification Date:
2025-12-17 @ 3:34 AM
Study NCT ID:
NCT05695391
Status:
None
Last Update Posted:
2025-07-09 00:00:00
First Post:
2022-12-21 00:00:00
Brief Title:
A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM
Sponsor:
Organization:
Laboratoire français de Fractionnement et de Biotechnologies
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
19
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: